| related words |
| hematide |
| novel |
| investigational |
| vaccine |
| cubicin |
| gene |
| bidil |
| tablet |
| receptive |
| feraheme |
| soliris |
| orphan |
| cryoablation |
| nexavar |
| ipsen |
| antibody |
| labeling |
| recothrom |
| myvax |
| immunotherapy |
|
| related documents |
| 912183--2/27/2009--CUBIST_PHARMACEUTICALS_INC |
| 918112--9/28/2010--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/ |
| 1178104--9/24/2010--CARDICA_INC |
| 1412067--5/6/2010--Oncothyreon_Inc. |
| 1318310--2/25/2010--ev3_Inc. |
| 881524--3/10/2010--VIVUS_INC |
| 729922--2/24/2010--OSI_PHARMACEUTICALS_INC |
| 1285819--3/31/2010--OMEROS_CORP |
| 1235010--3/12/2010--MOMENTA_PHARMACEUTICALS_INC |
| 1446847--3/30/2010--IRONWOOD_PHARMACEUTICALS_INC |
| 1159036--3/12/2010--HALOZYME_THERAPEUTICS_INC |
| 1428156--3/10/2010--Celera_CORP |
| 882796--3/9/2010--BIOCRYST_PHARMACEUTICALS_INC |
| 1008848--2/26/2010--ACORDA_THERAPEUTICS_INC |
| 918112--8/31/2009--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/ |
| 1178104--9/18/2009--CARDICA_INC |
| 1318310--2/27/2009--ev3_Inc. |
| 1412067--3/30/2009--Oncothyreon_Inc. |
| 729922--2/27/2009--OSI_PHARMACEUTICALS_INC |
| 1235010--3/13/2009--MOMENTA_PHARMACEUTICALS_INC |
|
| related topics |
| {product, candidate, development} |
| {product, liability, claim} |
| {stock, price, operating} |
| {gas, price, oil} |
| {property, intellectual, protect} |
| {loss, insurance, financial} |
| {product, market, service} |
| {acquisition, growth, future} |
| {debt, indebtedness, cash} |
| {provision, law, control} |
| {system, service, information} |
| {tax, income, asset} |
| {control, financial, internal} |
| {investment, property, distribution} |
| {regulation, change, law} |
| {customer, product, revenue} |
| {cost, contract, operation} |
| {cost, operation, labor} |
| {personnel, key, retain} |
| {regulation, government, change} |
|